The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease
Open accessAbstract
Background & aims Increased body iron, genetic hemochromatosis (GH) mutations, and nonalcoholic fatty liver disease (NAFLD) tend to cluster in carbohydrate-intolerant patients. In an attempt to further clarify the interrelationships among these conditions, we studied 42 carbohydrate-intolerant patients who were free of the common GH mutations C282Y and H63D, and had a serum iron saturation lower than 50%.Methods We measured body iron stores, and induced iron depletion to a level of near-iron deficiency (NID) by quantitative phlebotomy.Results In the 17 patients with clinical evidence of NAFLD, we could not demonstrate supranormal levels of body iron (1.6 +/- 0.2 vs. 1.4 +/- 0.2 g; P = 0.06). However, at NID, there was a 40%-55% improvement (P = 0.05-0.0001) of both fasting and glucose-stimulated plasma insulin concentrations, and near-normalization of serum alanine aminotransferase activity (from 61 +/- 5 to 32 +/- 2 IU/L; P < 0.001).Conclusions These results reflect the insulin-sparing effect of iron depletion and indicate a key role of iron and hyperinsulinemia in the pathogenesis of NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Iron is also strongly implicated in non-alcoholic steatohepatitis, considered an early marker of insulin resistance [622-624].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Immunoassay of insulin with insulin-antibody precipitate
Hales, C. N., & Pj, R. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,640
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander‐Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,137
Carter, P. M. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90405-2 · Cited by 787
Flagged first, then by citations
2 of the 53 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Bergmeyer, 1986, IFCC method for alanine and aspartate aminotransferase, J Clin Chem Clin Biochem, 24, 481
Cited by
Sorted by citations
Items 101–200 of 233
Iron chelation beyond transfusion iron overload
Pietrangelo, A. (2007) · American Journal of Hematology · doi:10.1002/ajh.21101 · Cited by 38
Iron as a therapeutic target in chronic liver disease
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i4.616 · Cited by 42
Iron and Hepatic Carcinogenesis
Tirnitz‐Parker, J. E. E., Glanfield, A., Olynyk, J. K., & Ramm, G. A. (2013) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2013007759 · Cited by 42
Management of Nonalcoholic Steatohepatitis
Agrawal, S., & Bonkovsky, H. L. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200209000-00011 · Cited by 36
Lim, R., Tuvia, K., Hajdu, C. H., Losada, M., Gupta, R., Parikh, T., Babb, J. S., & Taouli, B. A. (2010) · American Journal of Roentgenology · doi:10.2214/ajr.09.3036 · Cited by 35
Etiopatogenia de la esteatohepatitis no alcohólica
Pérez-Aguilar, F. (2005) · Gastroenterología y Hepatología · doi:10.1157/13077761 · Cited by 33
Lecube, A., Hernández, C., & Simó, R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.972 · Cited by 33
Platelets in Non-alcoholic Fatty Liver Disease
Dalbeni, A., Castelli, M., Zoncapè, M., Minuz, P., & Sacerdoti, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.842636 · Cited by 33
Utzschneider, K. M., Largajolli, A., Bertoldo, A., Marcovina, S., Nelson, J. E., Yeh, M. M., Kowdley, K. V., & Kahn, S. E. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.11.007 · Cited by 33
Near-iron deficiency-induced remission of gouty arthritis
Facchini, F. S. (2003) · Rheumatology · doi:10.1093/rheumatology/keg402 · Cited by 30
Self-citationNon-alcoholic fatty liver disease: treatment options based on pathogenic considerations
Oneta, C. (2002) · Swiss Medical Weekly · doi:10.4414/smw.2002.10001 · Cited by 29
Scheen, A. J., & Luyckx, F. (2003) · Acta Clinica Belgica · doi:10.1179/acb.2003.58.2.006 · Cited by 27
Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target
Chen, H. (2022) · Liver Research · doi:10.1016/j.livres.2022.09.003 · Cited by 24
Nonalcoholic Fatty Liver Disease
Sanyal, A. J. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.014 · Cited by 53
Cholecystectomy as a risk factor for non-alcoholic fatty liver disease development
Rodríguez‐Antonio, I., López-Sánchez, G. N., Garrido-Camacho, V. Y., Uribe, M., Chávez-Tapia, N. C., & Nuño‐Lámbarri, N. (2020) · HPB · doi:10.1016/j.hpb.2020.07.011 · Cited by 23
Crawford, D. H., Ross, D. G. F., Jaskowski, L., Burke, L. J., Britton, L. J., Musgrave, N., Briskey, D. R., Rishi, G., Bridle, K. R., & Subramaniam, V. N. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166142 · Cited by 23
Imajo, K., Kessoku, T., Honda, Y., Hasegawa, S., Tomeno, W., Ogawa, Y., Motosugi, U., Saigusa, Y., Yoneda, M., Kirikoshi, H., et al. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27810 · Cited by 23
Khodadoostan, M., Zamanidoost, M., Shavakhi, A., Sanei, H., Shahbazi, M., & Ahmadian, M. (2017) · Advanced Biomedical Research · doi:10.4103/2277-9175.200787 · Cited by 23
Review: Advances in the treatment of nonalcoholic fatty liver disease
Mehta, S. R. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810379587 · Cited by 24
Histological Resolution of Steatohepatitis After Iron Depletion
Riquelme, A. J., Soza, A., Nazal, L., Martínez, G., Marianne Kolbach, R., Patillo, A., Arellano, M. J. S., Duarte, I., Martínez, J., Molgó, M., et al. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000034564.68307.39 · Cited by 23
Yang, J., Chou, C., Yang, W., Ho, H., Yang, Y., & Chen, M. (2015) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.11.025 · Cited by 24
Ye, P., Cheah, I. K.-M., & Halliwell, B. B. (2013) · Free Radical Research · doi:10.3109/10715762.2013.806796 · Cited by 22
Wang, J., Jin, C., Ke, J.-F., Ma, Y.-L., Wang, Y., Lu, J., Li, M., & Li, L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.942412 · Cited by 22
Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy
Miyanishi, K. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.593 · Cited by 22
Chen, S. C., Huang, Y. F., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048645 · Cited by 21
Waldvogel-Abramovski, S., Waeber, G., Gassner, C., Buser, A. S., Frey, B. M., Favrat, B., & Tissot, J. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.10.001 · Cited by 20
Hayashi, N., Miyati, T., Minami, T., Takeshita, Y., Ryu, Y., Matsuda, T., Ohno, N., Hamaguchi, T., Kato, K., Takamura, T., et al. (2012) · Radiological Physics and Technology · doi:10.1007/s12194-012-0191-0 · Cited by 20
Delghingaro‐Augusto, V., Madad, L., Chandra, A., Simeonovic, C. J., Dahlstrom, J. E., & Nolan, C. J. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.024 · Cited by 20
Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.
Stengel, J. Z., & Harrison, S. A. (2006) · Europe PMC (PubMed Central) · Cited by 20
The Role of Iron in Nonalcoholic Fatty Liver Disease: The Story Continues
Kowdley, K. V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.023 · Cited by 20
Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy
Khedmat, H., & Taheri, S. (2011) · Hepatitis Monthly · Cited by 19
WANG, M., Zhao, S.-P., & TAN, M. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4749 · Cited by 18
Sumida, Y., Kanemasa, K., Fukumoto, K., Yoshida, N., & Sakai, K. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00152.x · Cited by 19
Hepcidin: inflammation's iron curtain
McGrath, H. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh345 · Cited by 19
Zacharski, L. R., Chow, B. K., Howes, P. S., Lavori, P. W., & Shamayeva, G. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.027 · Cited by 19
Nash, insulin resistance and iron
MACHADO, M., & CORTEZ‐PINTO, H. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01394.x · Cited by 18
Pathogenesis of Nonalcoholic Fatty Liver Disease
Machado, M. V., & Diehl, A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00025-2 · Cited by 17
Lee, S. H., Jeong, S., Lee, D., Lee, J. H., Hwang, S. H., Cho, Y. A., Park, Y. S., Hwang, J., Kim, J., Kim, N., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d347d9 · Cited by 17
Nakagawa, T., Muramoto, Y., Hori, M., 修一, 三., Marubayashi, T., & Nakagawa, K. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.08.004 · Cited by 17
Pharmacologic management of nonalcoholic fatty liver disease
Harrison, S. A., & Neuschwander‐Tetri, B. A. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.011 · Cited by 16
Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis
Xiong, F., Zhou, Q., Huang, X., Cao, P., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1055793 · Cited by 15
Wang, K., Yang, F., Zhang, P., Yang, Y., & Li, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.964163 · Cited by 15
Strategies for dissecting genetic-environmental interactions in neurodegenerative disorders
Schmechel, D. E., Browndyke, J. N., & Ghio, A. J. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.021 · Cited by 15
Association of insulin resistance with serum ferritin and aminotransferases-iron hypothesis
Huang, J. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i4.232 · Cited by 14
Arain, S. A., Kazi, T. G., Afridi, H. I., Abbasi, A. R., Ullah, N., Panhwar, A. H., & Siraj, S. (2015) · Analytical Methods · doi:10.1039/c5ay01785h · Cited by 13
Peretz, G., Link, G., Pappo, O., Bruck, R., & Ackerman, Z. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i2.240 · Cited by 13
Lainé, F., Reymann, J., Morel, F. M. M., Langouët, S., PERRIN, M., Guillygomarc’h, A., Brissot, P., Turmel, V., Mouchel, C., Pape, D., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03116.x · Cited by 13
The wide spectrum of steatohepatitis
Lonardo, A., Bagni, A., Tarugi, P., & Loria, P. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200410000-00015 · Cited by 13
Zacharski, L. R., & Gerhard, G. S. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm492ed · Cited by 13
Sebastiani, G., & Pantopoulos, K. (2010) · CRC Press eBooks · doi:10.1201/9781420059984-c13 · Cited by 12
Non‐Alcoholic Fatty Liver Disease
Day, C. (2004) · doi:10.1002/9780470987025.ch26 · Cited by 12
Karnchanasorn, R., Ou, H., Lin, J. L., Chuang, L., & Chiu, K. C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0790-y · Cited by 10
Habeos, I. G., Psyrogiannis, A. I., Kyriazopoulou, V. E., Psilopanagiotou, A., Papavassiliou, A. G., & Vagenakis, A. G. (2003) · HORMONES · doi:10.14310/horm.2002.1183 · Cited by 8
Nonalcoholic Fatty Liver Disease
Palmer, M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0548-5_10 · Cited by 12
Abbate, M., Montemayor, S., Mascaró, C. M., Casares, M., Gómez, C., Ugarriza, L., Tejada, S., Abete, I., Zulet, M. Á., Sureda, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143187 · Cited by 9
Li, Z., Cui, C., Xu, L., Ding, M., & Wang, Y. (2024) · Free Radical Research · doi:10.1080/10715762.2024.2417279 · Cited by 9
Mateo‐Gállego, R., Lacalle, L., Pérez‐Calahorra, S., Marco-Benedí, V., Recasens, V., Padrón, N., Lamíquiz-Moneo, I., Baila-Rueda, L., Jarauta, E., Calmarza, P., et al. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.06.017 · Cited by 8
Nash As Part of the Metabolic (Insulin Resistance) Syndrome
Marchesini, G., & Bugianesi, E. (2004) · Wiley eBooks · doi:10.1002/9780470987438.ch5 · Cited by 8
The Role of Estrogen Signaling in Cellular Iron Metabolism in Pancreatic β Cells
Taneera, J., Ali, A., & Hamad, M. A. (2022) · Pancreas · doi:10.1097/mpa.0000000000001978 · Cited by 7
Retinoids as Promising Treatment for Non-alcoholic Fatty Liver Disease
Tsuchiya, H. (2012) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.132.903 · Cited by 7
Pérez-Aguilar, F., Benlloch, S., & Berenguer, M. (2004) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)70517-2 · Cited by 7
Nonalcoholic Fatty Liver Disease
Reid, A. E. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6189-2.00085-8 · Cited by 6
Ware, W. R. (2010) · Cited by 6
Bacon, B. R., Adams, P. C., Kowdley, K. V., Powell, L. W., & Tavill, A. S. (2011) · Cited by 6
Wood, M. J., Gonsalkorala, E. S., & Powell, L. W. (2014) · Frontiers in diabetes · doi:10.1159/000357254 · Cited by 6
Non‐Alcoholic Fatty Liver Disease
Day, C. P. (2010) · doi:10.1002/9781444314403.ch29 · Cited by 6
Frazer, D. M., Anderson, G. J., Ramm, G. A., Subramaniam, V. N., & Powell, L. W. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.3.287 · Cited by 5
A retinoic acid receptor agonist tamibarotene suppresses iron accumulation in the liver
Yoshikawa, O., Ebata, Y., Tsuchiya, H., Kawahara, A., Kojima, C., Ikeda, Y., Hama, S., Kogure, K., Shudo, K., & Shiota, G. (2013) · Obesity · doi:10.1002/oby.20013 · Cited by 5
Clinical Manifestations and Diagnosis of NAFLD
Harrison, S. A., & Neuschwander‐Tetri, B. A. (2004) · doi:10.1002/9780470987438.ch13 · Cited by 5
On Stress and the Liver: A Chicken and Egg Conundrum
Bonkovsky, H. L. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.024 · Cited by 5
Mascitelli, L., Goldstein, M. R., & Zacharski, L. R. (2016) · Diabetes Care · doi:10.2337/dc16-0538 · Cited by 5
Ghorbel, H., Feki, I., Friha, I., Khabir, A., Boudawara, T., Boudawara, M., & Sayadi, S. (2011) · Endocrine · doi:10.1007/s12020-011-9483-0 · Cited by 5
Oxidative Stress and Hepatic Iron Overload
Pelusi, S., Valenti, L. V. C., & Fargion, S. R. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-15539-5_15 · Cited by 4
Spahr, L., & Hadengue, A. (2007) · doi:10.1002/9780470691861.ch12d · Cited by 4
Management of NASH: Current and Future Perspectives on Treatment
Angulo, P., & Lindor, K. D. (2004) · doi:10.1002/9780470987438.ch16 · Cited by 4
Démarche clinique devant une hyperferritinémie
Sogni, P., & Buffet, C. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.05.015 · Cited by 3
Okonkwo, P. O. (2014) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2014/11811 · Cited by 3
Hemochromatosis and Iron Storage Disorders
Bacon, B. R., & Britton, R. S. (2011) · Wiley eBooks · doi:10.1002/9781119950509.ch30 · Cited by 3
Tratamiento médico de la hepatopatía grasa no alcohólica primaria
Sánchez, D. M. (2005) · Medicina Clínica · doi:10.1157/13076737 · Cited by 3
Molecular Pathogenesis of Nonalcoholic Steatohepatitis
Alisi, A., Nobili, V., Otogawa, K., & Kawada, N. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070463 · Cited by 3
Nonalcoholic Fatty Liver Disease: Clinical Features, Disease Modifiers, and Natural History
Torres, D. M., & Harrison, S. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20538-0_9 · Cited by 2
Lonardo, A. (2023) · Exploration of Drug Science · doi:10.37349/eds.2023.00016 · Cited by 2
Insulin signaling, glucose metabolism oxidative stress, and aging
Facchini, F. S. (2003) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(03)14002-3 · Cited by 2
Self-citationImproving Detection of Siderotic Nodules in Patients with Liver Disease Using 2D ESWAN Technique
Yuan, Z., Shen, Z. Z., Guo, L., Wang, X., Wang, S., & Zhao, B. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.03.008 · Cited by 2
Kanda, T., Nakamoto, S., Yasui, S., Nakamura, M., Miyamura, T., Wu, S., Jiang, X., Arai, M., Imazeki, F., & Yokosuka, O. (2014) · Case Reports in Oncology · doi:10.1159/000362869 · Cited by 2
Pharmacological agents for nonalcoholic steatohepatitis
Guillaume, M., & Ratziu, V. (2013) · Hepatology International · doi:10.1007/s12072-013-9482-8 · Cited by 2
Neuschwander‐Tetri, B. A. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50060-7 · Cited by 2
Noninvasive determination of iron cumulation in the rat liver with lead intoxication
Lubyanova, I. P., Krasnokutskaya, L. M., Dmytrukha, N. M., Lehkostup, L. A., Войтович, І. Д., Primin, M. A., Владимирович, Н. И., Minova, Y. D., Sutkovoy, P. L., & Budnik, N. (2011) · Ukrainian Journal of Occupational Health · doi:10.33573/ujoh2011.03.043 · Cited by 2
Hormati, A., Khanyabi, A., Ahmadpour, S., Alemi, F., Sarkeshikian, S. S., Afifian, M., Mohammadbeig, A., & Ghadir, M. R. (2022) · Journal of Advances in Medical and Biomedical Research · doi:10.30699/jambs.30.143.493 · Cited by 2
Elebrashy, I., Shaker, O. G., Abdelgalil, S. I., & Yousief, E. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_100_19 · Cited by 2
Mora‐Gonzalez, D., Moreno‐Cabañas, A., García, L. G., Cobo‐Cuenca, A. I., Muñoz‐Turrillas, M. D. C., Mora‐Rodríguez, R., & Morales‐Palomo, F. (2025) · British Journal of Haematology · doi:10.1111/bjh.70270 · Cited by 1
Ni, Z., Wang, R., Miao, H., Wang, G., Lim, W. L. F., Zhang, S., Lam, S. M., & Shui, G. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.02.067 · Cited by 1
Crawford, D. H., Fletcher, L. M., & Kowdley, K. V. (2011) · Humana Press eBooks · doi:10.1007/978-1-60327-485-2_22 · Cited by 1
Non-Alcoholic Fatty Liver Disease
Alhadyan, R. H. M., Khojah, A. A. Y., & Alanazi, A. G. A. (2018) · The Egyptian Journal of Hospital Medicine · doi:10.12816/0043808 · Cited by 1
Nonalcoholic Fatty Liver (NAFL): Overview
Caldwell, S. H., Al‐Osaimi, A. M. S., Chang, C., Davis, C. A., Hespenheide, E. E., Krugner-Higby, L. A., Hylton, A. I., Iezzoni, J. C., Le, T. H., Nakamoto, R. K., et al. (2005) · doi:10.1007/4-431-27172-4_1 · Cited by 1
Vaquero, M. P. (2018) · Current Research in Diabetes & Obesity Journal · doi:10.19080/crdoj.2018.08.555727 · Cited by 1
Sidorenko, D. V., Назаров, В. Д., Lapin, S. V., & Emanuel, V. L. (2020) · Medical alphabet · doi:10.33667/2078-5631-2020-5-13-19 · Cited by 1
The Negative Association Between NAFLD Severity and CKD in a Non-Diabetic Gouty Population
Huang, Y., Zhou, Y., Wang, Y., Chi, J., Lv, W., Wang, Y., & Chen, Y. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1815-7559 · Cited by 1
Deugnier, Y., Bardou‐Jacquet, E., & Lainé, F. (2016) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30763-0 · Cited by 1
Colli, M. L. (2007) · Americanae (AECID Library) · Cited by 1
Metadata
- Authors
- Facchini, F. S., Hua, N. W., & Stoohs, R. A.
- Affiliations
- San Francisco General Hospital (US)
- Stanford Medicine (US)
- ORCID
- Stoohs, Riccardo A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 122
- Issue
- 4
- Pages
- 931-939
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2135385594
- Cited by
- 233
- References
- 53
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 13 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 10 · 2015: 15 · 2014: 10 · 2013: 11 · 2012: 11
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- Kaiser Foundation Research Institute
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- non-alcoholic fatty liver disease, iron depletion, carbohydrate intolerance, iron deficiency, iron stores, insulin resistance, hyperinsulinemia, insulin-sparing effect, alanine aminotransferase, hereditary hemochromatosis
- MeSH terms
- Adult, Alanine Transaminase, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Carbohydrates, Fatty Liver, Female, Hemochromatosis, Humans, Hyperinsulinism, Insulin, Iron, Male, Middle Aged, Phlebotomy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
